| 3.60 Data as of 3:58pm ET | -0.18 / -4.76%Today’s Change | 1.55 Today|||52-Week Range 4.20 | +45.16% Year-to-Date |
The 2 analysts offering 12-month price forecasts for Neogenomics Inc have a median target of 4.75, with a high estimate of 5.00 and a low estimate of 4.50. The median estimate represents a +31.94% increase from the last price of 3.60.

The current consensus among 4 polled investment analysts is to Buy stock in Neogenomics Inc. This rating has held steady since May, when it was unchanged from a rating.Move your mouse over past
months for detail

Move your mouse over a quarter or year to see how estimates have changed over time.




